204
Participants
Start Date
August 10, 2018
Primary Completion Date
April 28, 2021
Study Completion Date
April 28, 2021
Tofacitinib
tablets, 5 mg BID x 6 months
Placebo
tablets, to match tofacitinib 5 mg BID x 3 months
Tofacitinib
tablets, 5 mg BID x 3 months
Peking University First Hospital, Beijing
Rheumatology and Immunology Department, Xuanwu Hospital Capital Medical University, Beijing
Peking Union Medical College Hospital, Beijing
Rheumatology Department, The first Affiliated Hospital of Harbin Medical University, Harbin
Zhongshan Hospital Fudan University, Shanghai
Huashan Hospital, Fudan University, Shanghai
Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai
Nanjing Drum Tower Hospital, Nanjing
Jiangsu Province Hospital, Nanjing
Department of Rheumatology, The First People's Hospital of Changzhou, Changzhou
Department of Rheumatology ,The First Affiliated Hospital of Soochow University, Suzhou
Department of Rheumatology, Northern Jiangsu People's Hospital, Yangzhou
Affiliated Hospital of Nantong University, Nantong
Anhui Provincial Hospital, Hefei
The First Affiliated Hospital of Anhui Medical University/Rheumatology Department, Hefei
The First Affiliated Hospital of Bengbu Medical College, Bengbu
Linyi People's Hospital, Linyi
Tianjin Medical University General Hospital, Rheumatology and Immunology Department, Tianjin
Sir Run Run Shaw Hospital, School of Medicine, Zhejiang University, Hangzhou
The First Affiliated Hospital of Wenzhou Medical University, Wenzhou
Jiu Jiang No.1 People's Hospital, Jiujiang
Pingxiang People's Hospital, Pingxiang
The First Affiliated Hospital of Xiamen University, Xiamen
The First Affiliated Hospital of Army Medical University, PLA, Chongqing
Xiangya Hospital Central South University, Changsha
The Second Xiangya Hospital of Central South University, Changsha
Zhuzhou Central Hospital, Zhuzhou
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan
The First Affiliated Hospital of Zhengzhou University, Zhengzhou
The First Affiliated Hospital, Sun Yat-sen University, Guangzhou
Guangzhou First People's Hospital, Guangzhou
Guangdong Second Provincial General Hospital, Guangzhou
Department of Rheumatology and Immunology,West China Hospital,Sichuan University, Chengdu
First Affiliated Hospital of Kunming Medical University, Kunming
The First Affiliated Hospital of Xi'an Jiaotong University, Xi’an
The Third Hospital of Hebei Medical University, Rheumatology and Immunology Department, Shijiazhuang
The First Affiliated Hospital of Baotou Medical College, Baotou
The First hospital of Jilin University, Changchun
Lead Sponsor
Pfizer
INDUSTRY